Priority Date: 21.06.16 (US 201662352642P)

HEMOGLOBIN-TARGETED DRUG DELIVERY FOR THE TREATMENT OF CANCER

  • Application ID: EP17814862
  • Status: Request for examination was made

Attorney

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1346.07
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). J A Kemp is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.06.2016 - Priority Date (US 201662352642P)
  • 28.12.2017 - Publication A1 (WO2017221185)
  • 24.04.2019 - Publication A1 (EP3471775)